Androgens, Male Hypogonadism and Traumatic Brain Injury

DOI: 10.4236/ojemd.2014.41002   PDF   HTML     3,306 Downloads   5,471 Views   Citations

Abstract

Traumatic brain injury (TBI) is a worldwide public health problem. Populations with a growing number of vehicles are experiencing many traumas and accidents. The highest-risk group is young men. Significant advances in neurosurgery and intensive therapy have resulted in increased survival rates of TBI patients. These higher survival rates, in turn, have led to an increasingly higher number of patients with neurological, cognitive, clinical, and social problems. This lack of knowledge about TBI has been called by some “the silent epidemic”. In recent years, studies of patients with moderate and severe TBI are increasing. Glasgow Coma Scale ≤ 8 and abnormal pupils at admission are used to determine the prognosis of patients with moderate or severe TBI. Several biomarkers such as interleukins, thiobarbituric acid reactive species, and some hormones have been studied in an effort to aid prognosis. Testosterone plays a key role in men. Thus, an understanding of androgens in TBI is essential to follow these survivors of head trauma. This review will discuss the epidemiology of TBI, its association with male hypogonadism, and possible treatments.

Share and Cite:

Hohl, A. , Ronsoni, M. , Sande-Lee, S. , Vieira, F. , Schwarzbold, M. , Diaz, A. and Walz, R. (2014) Androgens, Male Hypogonadism and Traumatic Brain Injury. Open Journal of Endocrine and Metabolic Diseases, 4, 13-23. doi: 10.4236/ojemd.2014.41002.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] N. Andelic “The Epidemiology of Traumatic Brain Injury,” The Lancet Neurology, Vol. 12, No. 1, 2013, pp. 28-29. http://dx.doi.org/10.1016/S1474-4422(12)70294-6
[2] A. Hohl, T. L. Mazzuco, M. H. Coral, M. Schwarzbold and R. Walz, “Hypogonadism after Traumatic Brain Injury,” Arquivos Brasileiros de Endocrinologia & Metabologia, Vol. 53, No. 8, 2009, pp. 908-914.
http://dx.doi.org/10.1590/S0004-27302009000800003
[3] D. J. Thurman, C. Alverson, K. A. Dunn, J. Guerrero and J. E. Sniezek, “Traumatic Brain Injury in the United States: A Public Health Perspective,” The Journal of Head Trauma Rehabilitation, Vol. 14, No. 6, 1999, pp. 602-615. http://dx.doi.org/10.1097/00001199-199912000-00009
[4] F. Tagliaferri, C. Compagnone, M. Korsic, F. Servadei and J. Kraus, “A Systematic Review of Brain Injury Epidemiology in Europe,” Acta Neurochirurgica (Wien), Vol. 148, No. 3, 2006, pp. 255-268.
http://dx.doi.org/10.1007/s00701-005-0651-y
[5] R. N. R. Fernandes and M. Silva, “Epidemiology of Traumatic Brain Injury in Brazil,” Arquivos Brasileiros de Neurocirurgia, Vol. 32, No. 3, 2013, pp. 136-142.
[6] R. J. Urban, “Hypopituitarism after Acute Brain Injury,” Growth Hormone & IGF Research, 2006, Vol. 16, Supplement A, pp. S25-S29.
[7] F. Tanriverdi, H. Senyurek, K. Unluhizarci, A. Selcuklu, F. F. Casanueva and F. Kelestimur, “High Risk of Hypopituitarism after Traumatic Brain Injury: A Prospective Investigation of Anterior Pituitary Function in the Acute Phase and 12 Months after Trauma,” The Journal of Clinical Endocrinology and Metabolism, Vol. 91, No. 6, 2006, pp. 2105-2111.
http://dx.doi.org/10.1210/jc.2005-2476
[8] F. Tanriverdi, H. Ulutabanca, K. Unluhizarci, A. Selcuklu, F. F. Casanueva and F. Kelestimur, “Pituitary Functions in the Acute Phase of Traumatic Brain Injury: Are They Related to Severity of the Injury or Mortality?” Brain Injury, Vol. 21, No. 4, 2007, pp. 433-439.
http://dx.doi.org/10.1080/02699050701311083
[9] A. Agha and C. J. Thompson, “High Risk of Hypogonadism after Traumatic Brain Injury: Clinical Implications,” Pituitary, Vol. 8, No. 3-4, 2005, pp. 245-249.
http://dx.doi.org/10.1007/s11102-005-3463-4
[10] M. O. van Aken and S. W. Lamberts, “Diagnosis and Treatment of Hypopituitarism: An Update,” Pituitary, Vol. 8, No. 3-4, 2005, pp. 183-191.
http://dx.doi.org/10.1007/s11102-006-6039-z
[11] S. Deb, I. Lyons, C. Koutzoukis, I. Ali and G. McCarthy, “Rate of Psychiatric Illness 1 Year after Traumatic Brain Injury,” The American Journal of Psychiatry, Vol. 156, No. 3, 1999, pp. 374-378.
[12] M. Schwarzbold, A. Diaz, E. T. Martins, A. Rufino, L. N. Amante, M. E. Thais, et al., “Psychiatric Disorders and Traumatic Brain Injury,” Journal of Neuropsychiatric Disease and Treatment, Vol. 4, No. 4, 2008, pp. 797-816.
[13] J. W. Tomlinson, N. Holden, R. K. Hills, K. Wheatley, R. N. Clayton, A. S. Bates, et al., West Midlands Prospective Hypopituitary Study Group, “Association between Premature Mortality and Hypopituitarism,” Lancet, Vol. 357, No. 9254, 2001, pp. 425-431.
http://dx.doi.org/10.1016/S0140-6736(00)04006-X
[14] V. Gasco, F. Prodam, L. Pagano, S. Grottoli, S. Belcastro, P. Marzullo, et al., “Hypopituitarism Following Brain Injury: When Does It Occur and How Best to Test?” Pituitary, Vol. 15, No. 1, 2012, pp. 20-24.
http://dx.doi.org/10.1007/s11102-010-0235-6
[15] T. P. Young, H. M. Hoaglin and D. T. Burke, “The Role of Serum Testosterone and TBI in the In-Patient Rehabilitation Setting,” Brain Injury, Vol. 21, No. 6, 2007, pp. 645-649.
http://dx.doi.org/10.1080/02699050701210426
[16] N. E. Carlson, L. A. Brenner, M. E. Wierman, C. Harrison-Felix, C. Morey, S. Gallagher, et al., “Hypogonadism on Admission to Acute Rehabilitation Is Correlated with Lower Functional Status at Admission and Discharge,” Brain Injury, Vol. 23, No. 4, 2009, pp. 336-344.
http://dx.doi.org/10.1080/02699050902788535
[17] R. Clapauch, D. J. Braga, L. P. Marinheiro, S. Buksman and Y. Schrank, “Risk of Late-Onset Hypogonadism (Andropause) in Brazilian Men over 50 Years of Age with Osteoporosis: Usefulness of Screening Questionnaires,” Arquivos Brasileiros de Endocrinologia & Metabologia, Vol. 52, No. 9, 2008, pp. 1439-1447.
http://dx.doi.org/10.1590/S0004-27302008000900006
[18] E. Ghigo, B. Masel, G. Aimaretti, J. Leon-Carrion, F. F. Casanueva, M. R. Dominguez-Morales, et al., “Consensus Guidelines on Screening for Hypopituitarism Following Traumatic Brain Injury,” Brain Injury, Vol. 19, No. 9, 2005, pp. 711-724.
http://dx.doi.org/10.1080/02699050400025315
[19] M. Lorenzo, R. Peino, A. I. Castro, M. Lage, V. Popovic, C. Dieguez, et al., “Hypopituitarism and Growth Hormone Deficiency in Adult Subjects after Traumatic Brain Injury: Who and When to Test,” Pituitary, Vol. 8, No. 3-4, 2005, pp. 233-237.
http://dx.doi.org/10.1007/s11102-006-6046-0
[20] N. E. Kokshoorn, M. J. Wassenaar, N. R. Biermasz, F. Roelfsema, J. W. Smit, J. A. Romijn, et al., “Hypopituitarism Following Traumatic Brain Injury: Prevalence Is Affected by the Use of Different Dynamic Tests and Different Normal Values,” European Journal of Endocrinology, Vol. 162, No. 1, 2010, pp. 11-18.
http://dx.doi.org/10.1530/EJE-09-0601
[21] J. Feibel, M. Kelly, L. Lee and P. Woolf, “Loss of Adrenocortical Suppression after Acute Brain Injury: Role of Increased Intracranial Pressure and Brain Stem Function,” The Journal of Clinical Endocrinology and Metabolism, Vol. 57, No. 6, 1983, pp. 1245-1250.
http://dx.doi.org/10.1210/jcem-57-6-1245
[22] J. M. Hackl, M. Gottardis, C. Wieser, E. Rumpl, C. Stadler, S. Schwarz, et al., “Endocrine Abnormalities in Severe Traumatic Brain Injury—A Cue to Prognosis in Severe Craniocerebral Trauma?” Intensive Care Medicine, Vol. 17, No. 1, 1991, pp. 25-29.
http://dx.doi.org/10.1007/BF01708405
[23] F. Della Corte, A. Mancini, D. Valle, F. Gallizzi, P. Carducci, V. Mignani, et al., “Provocative Hypothalamopituitary Axis Tests in Severe Head Injury: Correlations with Severity and Prognosis,” Critical Care Medicine, Vol. 26, No. 8, 1998, pp. 1419-1426.
http://dx.doi.org/10.1097/00003246-199808000-00030
[24] A. Agha, B. Rogers, D. Mylotte, F. Taleb, W. Tormey, J. Phillips, et al., Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clinical Endocrinology (Oxford), Vol. 60, No. 5, 2004, pp. 584-591.
http://dx.doi.org/10.1111/j.1365-2265.2004.02023.x
[25] I. Cernak, V. J. Savic, A. Lazarov, M. Joksimovic and S. Markovic, “Neuroendocrine Responses Following Graded Traumatic Brain Injury in Male Adults,” Brain Injury, Vol. 13, No. 12, 1999, pp. 1005-1015.
http://dx.doi.org/10.1080/026990599121016
[26] S. C. Lee, N. D. Zasler and J. S. Kreutzer, “Male Pituitary-Gonadal Dysfunction Following Severe Traumatic Brain Injury,” Brain Injury, Vol. 8, No. 6, 1994, pp. 571-577.
http://dx.doi.org/10.3109/02699059409151009
[27] A. Kleindienst, G. Brabant, C. Bock, C. Maser-Gluth and M. Buchfelder, “Neuroendocrine Function Following Traumatic Brain Injury and Subsequent Intensive Care Treatment: A Prospective Longitudinal Evaluation,” Journal of Neurotrauma, Vol. 26, No. 9, 2009, pp. 1435-1446. http://dx.doi.org/10.1089/neu.2008.0601
[28] J. Wagner, J. R. Dusick, D. L. McArthur, P. Cohan, C. Wang, R. Swerdloff, et al., “Acute Gonadotroph and Somatotroph Hormonal Suppression after Traumatic Brain Injury,” Journal of Neurotrauma, Vol. 27, No. 6, 2010, pp. 1007-1019. http://dx.doi.org/10.1089/neu.2009.1092
[29] D. Krahulik, J. Zapletalova, Z. Frysak and M. Vaverka, “Dysfunction of Hypothalamic-Hypophysial Axis after Traumatic Brain Injury in Adults,” Journal of Neurosurgery, Vol. 113, No. 3, 2010, pp. 581-584.
http://dx.doi.org/10.3171/2009.10.JNS09930
[30] Z. Olivecrona, P. Dahlqvist and L. O. Koskinen, “Acute Neuro-Endocrine Profile and Prediction of Outcome after Severe Brain Injury,” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol. 21, 2013, p. 33. http://dx.doi.org/10.1186/1757-7241-21-33
[31] N. K. Sundaram, E. B. Geer and B. D. Greenwald, “The Impact of Traumatic Brain Injury on Pituitary Function,” Endocrinology and Metabolism Clinics of North America, Vol. 42, No. 3, 2013, pp. 565-583.
http://dx.doi.org/10.1016/j.ecl.2013.05.003
[32] C. Berg, A. Oeffner, P. M. Schumm-Draeger, F. Badorrek, G. Brabant, B. Gerbert, et al., “Prevalence of Anterior Pituitary Dysfunction in Patients Following Traumatic Brain Injury in a German Multi-Centre Screening Program,” Experimental and Clinical Endocrinology & Diabetes, Vol. 118, No. 2, 2010, pp. 139-144.
http://dx.doi.org/10.1055/s-0029-1225611
[33] H. J. Schneider, M. Schneider, I. Kreitschmann-Andermahr, U. Tuschy, H. Wallaschofski, S. Fleck, et al., “Structured Assessment of Hypopituitarism after Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage in 1242 Patients: The German Interdisciplinary Database,” Journal of Neurotrauma, Vol. 28, No. 9, 2011, pp. 1693-1698. http://dx.doi.org/10.1089/neu.2011.1887
[34] A. Hohl, J. B. Daltrozo, C. G. Pereira, T. R. Weber, H. F. Pinto, J. da Silva Gullo, et al., “Late Evaluation of the Pituitary-Gonadal Axis in Survivors of Severe Traumatic Brain Injury,” Arquivos Brasileiros de Endocrinologia & Metabologia, Vol. 53, No. 8, 2009, pp. 1012-1019.
http://dx.doi.org/10.1590/S0004-27302009000800016
[35] G. Aimaretti, M. R. Ambrosio, C. Di Somma, M. Gasperi, S. Cannavo, C. Scaroni, et al., “Residual Pituitary Function after Brain Injury-Induced Hypopituitarism: A Prospective 12-Month Study,” The Journal of Clinical Endocrinology and Metabolism, Vol. 90, No. 11, 2005, pp. 6085-6092.
http://dx.doi.org/10.1210/jc.2005-0504
[36] V. Popovic, S. Pekic, D. Pavlovic, N. Maric, M. JasovicGasic, B. Djurovic, et al., “Hypopituitarism as a Consequence of Traumatic Brain Injury (TBI) and Its Possible Relation with Cognitive Disabilities and Mental Distress,” Journal of Endocrinological Investigation, Vol. 27, No. 11, 2004, pp. 1048-1054.
[37] A. Leal-Cerro, J. M. Flores, M. Rincon, F. Murillo, M. Pujol, F. Garcia-Pesquera, et al., “Prevalence of Hypopituitarism and Growth Hormone Deficiency in Adults Long-Term after Severe Traumatic Brain Injury,” Clinical Endocrinology, Vol. 62, No. 5, 2005, pp. 525-532.
http://dx.doi.org/10.1111/j.1365-2265.2005.02250.x
[38] H. J. Schneider, M. Schneider, B. Saller, S. Petersenn, M. Uhr, B. Husemann, et al., “Prevalence of Anterior Pituitary Insufficiency 3 and 12 Months after Traumatic Brain Injury,” European Journal of Endocrinology, Vol. 154, No. 2, 2006, pp. 259-265.
http://dx.doi.org/10.1530/eje.1.02071
[39] B. L. Herrmann, J. Rehder, S. Kahlke, H. Wiedemayer, A. Doerfler, W. Ischebeck, et al., “Hypopituitarism Following Severe Traumatic Brain Injury,” Experimental and Clinical Endocrinology & Diabetes, Vol. 114, No. 6, 2006, pp. 316-321. http://dx.doi.org/10.1055/s-2006-924254
[40] O. Kozlowski Moreau, E. Yollin, E. Merlen, W. Daveluy and M. Rousseaux, “Lasting Pituitary Hormone Deficiency after Traumatic Brain Injury,” Journal of Neurotrauma, Vol. 29, No. 1, 2012, pp. 81-89.
http://dx.doi.org/10.1089/neu.2011.2048
[41] A. Agha, B. Rogers, M. Sherlock, P. O’Kelly, W. Tormey, J. Phillips, et al., “Anterior Pituitary Dysfunction in Survivors of Traumatic Brain Injury,” Journal of Clinical Endocrinology and Metabolism, Vol. 89, No. 10, 2004, pp. 4929-4936.
http://dx.doi.org/10.1210/jc.2004-0511
[42] D. F. Kelly, I. T. Gonzalo, P. Cohan, N. Berman, R. Swerdloff and C. Wang, “Hypopituitarism Following Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage: A Preliminary Report,” Journal of Neurosurgery, Vol. 93, No. 5, 2000, pp. 743-752.
http://dx.doi.org/10.3171/jns.2000.93.5.0743
[43] M. Bondanelli, L. De Marinis, M. R. Ambrosio, M. Monesi, D. Valle, M. C. Zatelli, et al., “Occurrence of Pituitary Dysfunction Following Traumatic Brain Injury,” Journal of Neurotrauma, Vol. 21, No. 6, 2004, pp. 685-696.
http://dx.doi.org/10.1089/0897715041269713
[44] M. Klose, A. Juul, L. Poulsgaard, M. Kosteljanetz, J. Brennum and U. Feldt-Rasmussen, “Prevalence and Predictive Factors of Post-Traumatic Hypopituitarism,” Clinical Endocrinology, Vol. 67, No. 2, 2007, pp. 193-201.
http://dx.doi.org/10.1111/j.1365-2265.2007.02860.x
[45] S. Bavisetty, D. L. McArthur, J. R. Dusick, C. Wang, P. Cohan, W. J. Boscardin, et al., “Chronic Hypopituitarism after Traumatic Brain Injury: Risk Assessment and Relationship to Outcome,” Neurosurgery, Vol. 62, No. 5, 2008, pp. 1080-1093.
[46] H. J. Schneider, I. Kreitschmann-Andermahr, E. Ghigo, G. K. Stalla and A. Agha, “Hypothalamopituitary Dysfunction Following Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage: A Systematic Review,” JAMA, Vol. 298, No. 12, 2007, pp. 1429-1438.
http://dx.doi.org/10.1001/jama.298.12.1429
[47] S. A. Lieberman, A. L. Oberoi, C. R. Gilkison, B. E. Masel and R. J. Urban, “Prevalence of Neuroendocrine Dysfunction in Patients Recovering from Traumatic Brain Injury,” Journal of Clinical Endocrinology and Metabolism, Vol. 86, No. 6, 2001, pp. 2752-2756.
http://dx.doi.org/10.1210/jc.86.6.2752
[48] G. Aimaretti, M. R. Ambrosio, C. Di Somma, A. Fusco, S. Cannavo, M. Gasperi, et al., “Traumatic Brain Injury and Subarachnoid Haemorrhage Are Conditions at High Risk for Hypopituitarism: Screening Study at 3 Months after the Brain Injury,” Clinical Endocrinology, Vol. 61, No. 3, 2004, pp. 320-326.
http://dx.doi.org/10.1111/j.1365-2265.2004.02094.x
[49] D. Wachter, K. Gundling, M. F. Oertel, H. Stracke and D. K. Boker, “Pituitary Insufficiency after Traumatic Brain Injury,” Journal of Clinical Neuroscience, Vol. 16, No. 2, 2009, pp. 202-208.
http://dx.doi.org/10.1016/j.jocn.2008.01.009
[50] A. W. van der Eerden, M. T. Twickler, F. C. Sweep, T. Beems, H. T. Hendricks, A. R. Hermus, et al., “Should Anterior Pituitary Function Be Tested during Follow-Up of All Patients Presenting at the Emergency Department because of Traumatic Brain Injury?” European Journal of Endocrinology, Vol. 162, No. 1, 2010, pp. 19-28.
http://dx.doi.org/10.1530/EJE-09-0436
[51] N. E. Kokshoorn, J. W. Smit, W. A. Nieuwlaat, J. Tiemensma, P. H. Bisschop, R. Groote Veldman, et al., “Low Prevalence of Hypopituitarism after Traumatic Brain Injury: A Multicenter Study,” European Journal of Endocrinology, Vol. 165, No. 2, 2011, pp. 225-231.
http://dx.doi.org/10.1530/EJE-11-0365
[52] C. W. Wilkinson, K. F. Pagulayan, E. C. Petrie, C. L. Mayer, E. A. Colasurdo, J. B. Shofer, et al., “High Prevalence of Chronic Pituitary and Target-Organ Hormone Abnormalities after Blast-Related Mild Traumatic Brain Injury,” Frontiers in Neurology, Vol. 3, 2012, p. 11.
http://dx.doi.org/10.3389/fneur.2012.00011
[53] D. Baxter, D. J. Sharp, C. Feeney, D. Papadopoulou, T. E. Ham, S Jilka, et al., “Pituitary Dysfunction after Blast Traumatic Brain Injury: The UK BIOSAP Study,” Annals of Neurology, Vol. 74, No. 4, 2013, pp. 527-536.
http://dx.doi.org/10.1002/ana.23958
[54] T. Ulfarsson, G. Arnar Gudnason, T. Rosen, C. Blomstrand, K. S. Sunnerhagen, A. Lundgren-Nilsson, et al., “Pituitary Function and Functional Outcome in Adults After Severe Traumatic Brain Injury: The Long-Term Perspective,” Journal of Neurotrauma, Vol. 30, No. 4, 2013, pp. 271-280.
http://dx.doi.org/10.1089/neu.2012.2494
[55] R. M. Friedlander, “Apoptosis and Caspases in Neurodegenerative Diseases,” New England Journal of Medicine, Vol. 348, No. 14, 2003, pp. 1365-1375.
http://dx.doi.org/10.1056/NEJMra022366
[56] D. P. Graham and A. L. Cardon, “An Update on Substance Use and Treatment Following Traumatic Brain Injury,” Annals of the New York Academy of Sciences, Vol. 1141, 2008, pp. 148-162.
http://dx.doi.org/10.1196/annals.1441.029
[57] M. C. LaPlaca, C. M. Simon, G. R. Prado and D. K. Cullen, “CNS Injury Biomechanics and Experimental Models,” Progress in Brain Research, Vol. 161, 2007, pp. 13-26.
http://dx.doi.org/10.1016/S0079-6123(06)61002-9
[58] J. M. Spaethling, D. M. Geddes-Klein, W. J. Miller, C. R. von Reyn, P. Singh, M. Mesfin, et al., “Linking Impact to Cellular and Molecular Sequelae of CNS Injury: Modeling in Vivo Complexity with in Vitro Simplicity,” Progress in Brain Research, Vol. 161, 2007, pp. 27-39.
http://dx.doi.org/10.1016/S0079-6123(06)61003-0
[59] F. Dal-Pizzol, F. Klamt, M. M. Vianna, N. Schroder, J. Quevedo, M. S. Benfato, et al., “Lipid Peroxidation in Hippocampus Early and Late after Status Epilepticus Induced by Pilocarpine or Kainic Acid in Wistar Rats,” Neuroscience Letters, Vol. 291, No. 3, 2000, pp. 179-182.
http://dx.doi.org/10.1016/S0304-3940(00)01409-9
[60] F. Petronilho, G. Feier, B. de Souza, C. Guglielmi, L. S. Constantino, R. Walz, et al., “Oxidative Stress in Brain According to Traumatic Brain Injury Intensity,” Journal of Surgical Research, Vol. 164, No. 2, 2010, pp. 316-320.
http://dx.doi.org/10.1016/j.jss.2009.04.031
[61] M. L. Schwarzbold, D. Rial, T. De Bem, D. G. Machado, M. P. Cunha, A. A. dos Santos, et al., “Effects of Traumatic Brain Injury of Different Severities on Emotional, Cognitive, and Oxidative Stress-Related Parameters in Mice,” Journal of Neurotrauma, Vol. 27, No. 10, 2010, pp. 1883-1893.
http://dx.doi.org/10.1089/neu.2010.1318
[62] A. P. Diaz, M. L. Schwarzbold, M. E. de Oliveira Thais, G. G. Cavalazzi, R. Schmoeller, J. C. Nunes, A. Hohl, R. Guarnieri, M. N. Linhares and R. Walz, “Personality Changes and Return-to-Work after Severe Traumatic Brain Injury: A Prospective Study,” Revista Brasileira de Psiquiatria, 2014, in Press.
[63] A. Hohl, S. Gullo Jda, C. C. Silva, M. M. Bertotti, F. Felisberto, J. C. Nunes, et al., “Plasma Levels of Oxidative Stress Biomarkers and Hospital Mortality in Severe Head Injury: A Multivariate Analysis,” Journal of Critical Care, Vol. 27, No. 5, 2012, pp. 523e11-523e19.
[64] E. D. Hall, R. A. Vaishnav and A. G. Mustafa, “Antioxidant Therapies for Traumatic Brain Injury,” Neurotherapeutics, Vol. 7, No. 1, 2010, pp. 51-61.
http://dx.doi.org/10.1016/j.nurt.2009.10.021
[65] E. D. Hall and J. M. Braughler, “Central Nervous System Trauma and Stroke. II. Physiological and Pharmacological Evidence for Involvement of Oxygen Radicals and Lipid Peroxidation,” Free Radical Biology and Medicine, Vol. 6, No. 3, 1989, pp. 303-313.
http://dx.doi.org/10.1016/0891-5849(89)90057-9
[66] M. E. de Oliveira Thais, G. Cavallazzi, D. A. Formolo, L. D. de Castro, R. Schmoeller, R. Guarnieri, et al., “Limited Predictive Power of Hospitalization Variables for Long-Term Cognitive Prognosis in Adult Patients with Severe Traumatic Brain Injury,” Journal of Neuropsychology, Epub Ahead of Print, 2012.
http://dx.doi.org/10.1111/jnp.12000
[67] E. T. Martins, M. N. Linhares, D. S. Sousa, H. K. Schroeder, J. Meinerz, L. A. Rigo, et al., “Mortality in Severe Traumatic Brain Injury: A Multivariated Analysis of 748 Brazilian Patients from Florianopolis City,” Journal of Trauma, Vol. 67, No. 1, 2009, pp. 85-90.
http://dx.doi.org/10.1097/TA.0b013e318187acee
[68] F. M. Schneider Soares, N. Menezes de Souza, M. Liborio Schwarzbold, A. Paim Diaz, J. Costa Nunes, A. Hohl, et al., “Interleukin-10 Is an Independent Biomarker of Severe Traumatic Brain Injury Prognosis,” Neuroimmunomodulation, Vol. 19, No. 6, 2012, pp. 377-385.
http://dx.doi.org/10.1159/000342141
[69] A. P. Diaz, M. L. Schwarzbold, M. E. Thais, A. Hohl, M. M. Bertotti, R. Schmoeller, et al., “Psychiatric Disorders and Health-Related Quality of Life after Severe Traumatic Brain Injury: A Prospective Study,” Journal of Neurotrauma, Vol. 29, No. 6, 2012, pp. 1029-1037.
http://dx.doi.org/10.1089/neu.2011.2089
[70] N. V. Marsh and D. A. Kersel, “Frequency of Behavioural Problems at One Year Following Traumatic Brain Injury: Correspondence between Patient and Caregiver Reports,” Neuropsychological Rehabilitation, Vol. 16, No. 6, 2006, pp. 684-694.
http://dx.doi.org/10.1080/09602010500220290
[71] N. E. Skakkebaek, J. Toppari, O. Soder, C. M. Gordon, S. Divall and M. Draznin, “The Exposure of Fetuses and Children to Endocrine Disrupting Chemicals: A European Society for Paediatric Endocrinology (ESPE) and Pediatric Endocrine Society (PES) Call to Action Statement,” The Journal of Clinical Endocrinology and Metabolism, Vol. 96, No. 10, 2011, pp. 3056-3058.
http://dx.doi.org/10.1210/jc.2011-1269
[72] S. H. Swan, K. M. Main, F. Liu, S. L. Stewart, R. L. Kruse, A. M. Calafat, et al., “Decrease in Anogenital Distance among Male Infants with Prenatal Phthalate Exposure,” Environmental Health Perspectives, Vol. 113, No. 8, 2005, pp. 1056-1061.
http://dx.doi.org/10.1289/ehp.8100
[73] F. H. Pierik, A. Burdorf, J. A. Deddens, R. E. Juttmann and R. F. Weber, “Maternal and Paternal Risk Factors for Cryptorchidism and Hypospadias: A Case-Control Study in Newborn Boys,” Environmental Health Perspectives, Vol. 112, No. 15, 2004, pp. 1570-1576.
http://dx.doi.org/10.1289/ehp.7243
[74] E. L. Rhoden and A. Morgentaler, “Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring,” New England Journal of Medicine, Vol. 350, No. 5, 2004, pp. 482-492.
http://dx.doi.org/10.1056/NEJMra022251
[75] S. Bhasin, G. R. Cunningham, F. J. Hayes, A. M. Matsumoto, P. J. Snyder, R. S. Swerdloff, et al., “Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline,” The Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 6, 2010, pp. 2536-2559.
http://dx.doi.org/10.1210/jc.2009-2354
[76] G. Corona, G. Rastrelli, G. Forti and M. Maggi, “Update in Testosterone Therapy for Men,” Journal of Sexual Medicine, Vol. 8, No. 3, 2011, pp. 639-654.
http://dx.doi.org/10.1111/j.1743-6109.2010.02200.x
[77] V. A. Giagulli, V. Triggiani, G. Corona, D. Carbone, B. Licchelli, E. Tafaro, et al., “Evidence-Based Medicine Update on Testosterone Replacement Therapy (TRT) in Male Hypogonadism: Focus on New Formulations,” Current Pharmaceutical Design, Vol. 17, No. 15, 2011, pp. 1500-1511.
http://dx.doi.org/10.2174/138161211796197160
[78] G. Corona, G. Rastrelli, L. Vignozzi and M. Maggi, “Emerging Medication for the Treatment of Male Hypogonadism,” Expert Opinion on Emerging Drugs, Vol. 17, No. 2, 2012, pp. 239-259.
http://dx.doi.org/10.1517/14728214.2012.683411
[79] C. Wang, R. S. Swerdloff, A. Iranmanesh, A. Dobs, P. J. Snyder, G. Cunningham, et al., “Transdermal Testosterone Gel Improves Sexual Function, Mood, Muscle Strength, and Body Composition Parameters in Hypogonadal Men,” The Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 8, 2000, pp. 2839-2853.
http://dx.doi.org/10.1210/jc.85.8.2839
[80] C. Wang, N. Ilani, S. Arver, R. I. McLachlan, T. Soulis and A. Watkinson, “Efficacy and Safety of the 2% Formulation of Testosterone Topical Solution Applied to the Axillae in Androgen-Deficient Men,” Clinical Endocrinology, Vol. 75, No. 6, 2011, pp. 836-843.
http://dx.doi.org/10.1111/j.1365-2265.2011.04152.x
[81] C. Fennell, G. Sartorius, L. P. Ly, L. Turner, P. Y. Liu, A. J. Conway, et al., “Randomized Cross-Over Clinical Trial of Injectable vs. Implantable Depot Testosterone for Maintenance of Testosterone Replacement Therapy in Androgen Deficient Men,” Clinical Endocrinology, Vol. 73, No. 1, 2010, pp. 102-109.
[82] A. Hohl, M. O. Marques, M. H. Coral and R. Walz, “Evaluation of Late-Onset Hypogonadism (Andropause) Treatment Using Three Different Formulations of Injectable Testosterone,” Arquivos Brasileiros de Endocrinologia & Metabologia, Vol. 53, No. 8, 2009, pp. 989-995.
http://dx.doi.org/10.1590/S0004-27302009000800013
[83] R. M. Meirelles and A. Hohl, “Men’s Health: So Neglected, Mainly by Men,” Arquivos Brasileiros de Endocrinologia & Metabologia, Vol. 53, No. 8, 2009, pp. 899900.
http://dx.doi.org/10.1590/S0004-27302009000800001
[84] M. Zitzmann and E. Nieschlag, “Hormone Substitution in Male Hypogonadism,” Molecular and Cellular Endocrinology, Vol. 161, No. 1-2, 2000, p. 73-88.
http://dx.doi.org/10.1016/S0303-7207(99)00227-0

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.